|
Metodología | |||
| Adiponectin Human | ||||
 |
125 | RIA | ||
| Adiponectin Mouse | ||||
|
125 | RIA | ||
| C-Peptide Canine | ||||
|
125 | RIA | ||
| C-Peptide Human | ||||
|
250 | RIA | ||
| C-Peptide Porcine | ||||
|
250 | RIA | ||
| C-Peptide Rat | ||||
|
250 | RIA | ||
| Ghrelin (active) Human | ||||
|
125 | RIA | ||
| Ghrelin (total) Human | ||||
|
125 | RIA | ||
| Glucagon | ||||
|
250 | RIA | ||
| Glucagon-Like Peptide-1 (active) | ||||
|
125 | RIA | ||
| Glucagon-Like Peptide-1 (total) | ||||
|
125 | RIA | ||
| Growth Hormone Porcine/Canine | ||||
|
125 | RIA | ||
| Growth Hormone Rat | ||||
|
125 | RIA | ||
| Insulin Lispro | ||||
|
250 | RIA | ||
| Insulin Porcine | ||||
|
250 | RIA | ||
| Insulin Rat | ||||
|
250 |
|
||
| Insulin Sensitive Rat | ||||
|
250 | RIA | ||
| InsulinUltra Sensitive Human | ||||
|
250 | RIA | ||
| Insulin Specific Human | ||||
|
125 | RIA | ||
| Leptin Human | ||||
|
250 | RIA | ||
| Leptin Mouse | ||||
|
250 | RIA | ||
| Leptin Multi Species | ||||
|
250 | RIA | ||
| Leptin Rat | ||||
|
250 | RIA | ||
| Leptin Primate | ||||
|
250 | RIA | ||
| Leptin Sensitive Human | ||||
|
250 | RIA | ||
| Proinsulin Human | ||||
|
250 | RIA | ||
| PYY (total) Human | ||||
|
125 | RIA | ||
| PYY Rat / Mouse | ||||
|
125 | RIA | ||
| PYY (3-36) Specific Human | ||||
|
125 | RIA | ||
| Resistin Mouse | ||||
|
125 | RIA | ||